E. Cottura

A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies

Philippe Bédard, L. Siu, J. Rodon, 2015, British Journal of Cancer.

[Dermatologic side effects induced by new angiogenesis inhibitors].

C. Chevreau, V. Sibaud, V. Sibaud, 2011, Bulletin du cancer.

A phase I study of ixabepilone in combination with epirubicin in patients with metastatic breast cancer.

L. Gianni, F. Dalenc, M. Zambetti, 2012, Clinical breast cancer.

Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitors

D. Pouessel, C. Chevreau, F. Puisset, 2020, European Journal of Clinical Pharmacology.

Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2

J. Bonneterre, P. Fumoleau, V. Diéras, 2012, British Journal of Cancer.

Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitors

D. Pouessel, C. Chevreau, F. Puisset, 2020, European Journal of Clinical Pharmacology.